Volume 34, Issue 11 pp. 782-785

Case of adult T-cell leukemia/lymphoma manifesting marked purpura

Junna OKADA

Junna OKADA

Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

Search for more papers by this author
Shinichi IMAFUKU

Shinichi IMAFUKU

Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

Search for more papers by this author
Jun TSUJITA

Jun TSUJITA

Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

Search for more papers by this author
Yoichi MOROI

Yoichi MOROI

Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

Search for more papers by this author
Kazunori URABE

Kazunori URABE

Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

Search for more papers by this author
Masutaka FURUE

Masutaka FURUE

Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

Search for more papers by this author
First published: 25 October 2007
Citations: 9
Junna Okada, M.D., Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan. Email: [email protected]

ABSTRACT

We present a case of a 62-year-old woman with marked purpura, first appearing on both legs, then spreading over the whole body, including the face. At presentation, the patient was thought to have Henoch–Schonlein purpura. However, a skin biopsy from a purpuric lesion revealed prominent infiltrations of atypical lymphocytes into the papillary dermis and marked extravasation of erythrocytes through the epidermis and upper dermis. Antibody to human T-lymphotropic virus type 1 (HTLV-1) was present in the serum and samples from skin lesions revealed HTLV-1 proviral DNA integration, as well as a clonal T-cell receptor Cβ1 gene rearrangement. We therefore diagnosed this case as adult T-cell leukemia/lymphoma (ATL), and the purpuric lesions as ATL-specific. Soon after the initiation of chemotherapy, these purpuric lesions began to resolve with pigmentation.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.